Brivanib-impurities | Pharmaffiliates

brivanib

"Brivanib has been investigated for the treatment of Solid Tumors, Hepato Cellular Carcinoma (HCC), and Metastatic Colorectal Cancer (MCRC). It is under investigation for the treatment of HepatoCellular Carcinoma. . Reference standards of Brivanib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Brivanib - API Standards 
    [catalogue_number] => PA 02 45000
    [category_ids] => ,69,78,70,82,89,
    [chemical_name] => 
    [weight] => 370.38
    [form] => C19H19FN4O3
    [cas] => 649735-46-6
    [pslug] => 649735-46-6-brivanib-api-pa0245000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 02 45000

Brivanib - API Standards


  • Catalogue No.:PA 02 45000

  • CAS :

    649735-46-6

  • Molecular Formula : C19H19FN4O3

  • Molecular Weight : 370.38

stdClass Object
(
    [pname] => Brivanib Alaninate
    [catalogue_number] => PA 02 45510
    [category_ids] => 82,80,78,71,70,69
    [chemical_name] => 
    [weight] => 441.46
    [form] => C22H24FN5O4
    [cas] => 649735-63-7
    [pslug] => 649735-63-7-brivanib-alaninate-pa0245510
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 02 45510

Brivanib Alaninate


  • Catalogue No.:PA 02 45510

  • CAS :

    649735-63-7

  • Molecular Formula : C22H24FN5O4

  • Molecular Weight : 441.46

stdClass Object
(
    [pname] => 1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2,3,3,3-d4-2-ol
    [catalogue_number] => PA STI 088922
    [category_ids] => ,98,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 374.41
    [form] => C19H15D4FN4O3
    [cas] => NA
    [pslug] => 1-4-4-fluoro-2-methyl-1h-indol-5-yl-oxy-5-methylpyrrolo-2-1-f-1-2-4-triazin-6-yl-oxy-propan-2-3-3-3-d4-2-ol-pasti088922
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 088922

1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2,3,3,3-d4-2-ol


  • Catalogue No.:PA STI 088922

  • CAS :

    NA

  • Molecular Formula : C19H15D4FN4O3

  • Molecular Weight : 374.41

stdClass Object
(
    [pname] => Brivanib alaninate-d4
    [catalogue_number] => PA STI 088923
    [category_ids] => ,98,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 445.49
    [form] => C22H20D4FN5O4
    [cas] => NA
    [pslug] => brivanib-alaninate-d4-pasti088923
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 088923

Brivanib alaninate-d4


  • Catalogue No.:PA STI 088923

  • CAS :

    NA

  • Molecular Formula : C22H20D4FN5O4

  • Molecular Weight : 445.49